ARCHIVES

Tipping Resigned Forom ACS Following Volunteer Discontent

This article is from The Cancer Letter archive.

Vol. 17 No. 37 | September 27, 1991

Download PDF Visit The Full Archive

Related Articles

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000

American Home Products Changes Name To Wyeth.

March 1, 2002

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

In Brief: Four More O.I. Awards Announced; Pediatric Clinical Trials RFP Canceled

September 6, 1985